As a result, expression levels of CASK (p = 0.024), LAMA2 (p = 0.040), LY6D (p = 0.018), and CLDN4 (p = 0.043) were significantly associated with the overall survival of patients with urinary bladder carcinoma (Figure 5). Here, LAMA2 is linked to urinary bladder carcinoma.